Crossref logo
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Kim,Yong-Man et al.
Journal of Gynecologic Oncology(2019), 30 (3)
http://dx.doi.org/10.3802/jgo.2019.30.e32